8 Key Differences Between Omega-3 and Evening Primrose Oil for Menopause Symptoms
So many women grab evening primrose oil because it feels like a menopause tradition — something their mother or aunt swore by. And then they pick up omega-3s because they've heard it's good for everything. The truth is messier and more interesting than that, and once you understand the actual mechanisms, the choice stops feeling like a coin flip.
Learn more about Rose →They Contain Completely Different Types of Fatty Acids
Omega-3 supplements (typically from fish oil or algae) deliver EPA and DHA — long-chain polyunsaturated fatty acids that the body uses directly for anti-inflammatory signaling, brain function, and cardiovascular regulation. Evening primrose oil (EPO) contains gamma-linolenic acid (GLA), an omega-6 fatty acid that the body must convert through enzymatic steps before it becomes anti-inflammatory. This distinction matters because that conversion process is slow, inefficient in many women, and can be blocked by stress, aging, and certain dietary patterns.
Their Evidence Bases for Hot Flashes Are Not Equally Strong
Omega-3 supplementation has been tested in multiple randomized controlled trials for vasomotor symptoms, with a well-cited 2009 RCT and subsequent meta-analyses suggesting modest but real reductions in hot flash frequency — particularly for women not using hormone therapy. EPO's evidence for hot flashes is far thinner: one small RCT showed a reduction in hot flash intensity but not frequency, and the trial design had significant limitations. For this specific symptom, omega-3 has the more credible track record.
Evening Primrose Oil Has a Stronger Case for Skin and Moisture
GLA from EPO plays a structural role in maintaining the skin's lipid barrier — the layer that keeps moisture in and irritants out. Several studies show that GLA supplementation can improve skin hydration, elasticity, and roughness, which matters during menopause when declining estrogen noticeably thins and dries skin. Omega-3s also support skin health, but the evidence for EPO's specific role in barrier function is more targeted and consistent for this particular symptom.
Omega-3s Have Far More Robust Cardiovascular Evidence
Cardiovascular risk rises significantly after menopause as estrogen's protective effects on blood vessels and lipid profiles decline. EPA and DHA from omega-3s have decades of research supporting their role in reducing triglycerides, improving arterial flexibility, and modestly lowering inflammatory markers — all relevant to this post-menopausal risk shift. EPO has no comparable cardiovascular evidence base, and this difference alone makes omega-3s the more strategically important supplement for women in midlife.
Their Mechanisms for Mood Support Differ Significantly
EPA in particular has been studied extensively in depression research, with meta-analyses suggesting it has genuine antidepressant-adjacent effects through its influence on neuroinflammation and serotonin signaling — both of which are disrupted during the hormonal fluctuations of perimenopause. EPO's proposed mood benefits work indirectly through prostaglandin pathways and are less well-documented; most EPO-mood research has focused on PMS rather than menopause-specific mood changes. For women dealing with perimenopausal anxiety or low mood, omega-3s have the more credible biological rationale.
Evening Primrose Oil Carries a Seizure Risk That Omega-3s Do Not
EPO has a documented interaction with phenothiazine medications (used in some psychiatric conditions) and has been associated with lowering seizure threshold in susceptible individuals — a risk that appears in clinical pharmacology literature and on most evidence-based supplement databases. This is not a theoretical concern to dismiss: women with a history of seizures or on certain psychiatric medications should discuss EPO specifically with a healthcare provider before using it. Omega-3 fatty acids do not carry this risk.
Omega-3s Have a More Predictable Dosing Framework
The research on omega-3s for menopause symptoms has generally used doses of 1–2 grams of EPA+DHA daily, giving women and clinicians a reasonable reference point. EPO dosing in studies has varied widely — from 500mg to 4g daily — and because GLA's conversion to active metabolites is variable between individuals, the effective dose is genuinely harder to predict. This inconsistency makes it more difficult to know whether a given EPO dose is doing anything meaningful.
They Can Be Used Together, But That Doesn't Always Mean They Should Be
Since omega-3s and GLA from EPO operate through complementary rather than competing pathways, some practitioners suggest combining them — and there's no direct safety concern with doing so for most healthy women. However, 'can be combined' is not the same as 'should be combined by default,' and taking both without a clear symptom-specific reason means spending money on two supplements when one may be sufficient. A more useful approach is to match the supplement to the primary symptom — omega-3s for mood, cardiovascular support, and hot flashes; EPO for skin barrier and moisture — rather than defaulting to both out of caution.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.